Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Hormone Support Protocol

FertirelinComplete Dosing & Administration Guide

A potent GnRH analog designed to support reproductive function in veterinary and research settings

Dose Range

25 micrograms-100 microgramsmg

Frequency

Once daily

Route

Intramuscular injection

Cycle Length

Ongoing/indefinite

Dosing

How much
do I take?

Timing

Best time to take

Administer Fertirelin at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.

With food?

Fertirelin injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.

If stacking

Fertirelin should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

  • +You've tolerated the current dose for the recommended period without significant side effects
  • +Therapeutic goals haven't been met at the current dose level
  • +Your healthcare provider recommends dose escalation based on your response
  • +Lab work or clinical assessments support a higher dose

Decrease if

  • -Side effects are bothersome or impacting daily life despite management strategies
  • -You experience any signs of an adverse reaction
  • -Lab results indicate the need for dose reduction
  • -Your healthcare provider recommends a lower dose based on your response

Signs of right dose

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

1
2
3
4

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The weight is on the label

Peptide vial
5mg

Select Weight

mg

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do I
use it?

Reconstitution

What you need

  • Fertirelin vial (lyophilized powder or solution)
  • Bacteriostatic water or sterile sodium chloride for reconstitution
  • Alcohol swabs for cleaning vial tops and injection sites
  • Appropriately sized syringes with fine-gauge needles (27-30 gauge)
  • Sharps disposal container

Example

Add the recommended volume of bacteriostatic water to the Fertirelin vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.

Your dose of Fertirelin is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.

Injection

Route

Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Best sites

  • Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
  • Front of thighs—middle to upper portion of the outer leg
  • Back of upper arm—outer area (may need assistance from another person)

Technique

  • 1.Wash your hands thoroughly with soap and water before handling supplies
  • 2.Clean the injection site with an alcohol swab and let it air dry completely
  • 3.Pinch a fold of skin at the chosen injection site
  • 4.Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
  • 5.Inject the medication slowly and steadily over 5-10 seconds
  • 6.Release the skin fold and remove the needle, applying gentle pressure with a clean swab
  • 7.Rotate injection sites to prevent tissue irritation or lipodystrophy
  • 8.Dispose of the needle safely in a sharps container—never recap or reuse needles
Full Injection Guide

Storage

Before reconstitution

Store Fertirelin in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Fertirelin should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (once daily)

As prescribed by your healthcare provider injection

Site: Intramuscular injection—rotate sites if applicable

Maintain a consistent schedule for optimal results with Fertirelin. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is it
safe?

Safety Profile

Fertirelin is a GnRH agonist developed specifically for veterinary use in livestock, particularly cattle breeding and fertility management. The peptide has been safely used in veterinary medicine for over 40 years with a well-documented safety profile in animals. Important limitation: Fertirelin is NOT approved for human use. All safety and efficacy data comes from veterinary applications in cattle and limited laboratory research. Human safety data is minimal and extrapolation from veterinary use is problematic. The biphasic response (initial hormone surge followed by suppression) must be carefully managed in any application. Individual responses can vary significantly based on age, hormonal status, and concurrent medications.

Fertirelin's safety and efficacy data comes primarily from veterinary medicine, where it has been approved for cattle reproduction since 1981 in Japan. The peptide is 15-20 times more potent than natural GnRH at stimulating LH release. Human clinical data is extremely limited, with no FDA or EMA approval for any human indication.

Common Side Effects

Experienced by some users

Mild discomfort at treatment site

Some users experience mild discomfort, which is among the most commonly reported effects with Fertirelin. This typically resolves within a few days as the body adjusts.

Management: Apply ice if needed. Rotate treatment sites. These symptoms typically improve within the first week of use.

Transient hormone fluctuations

As a GnRH agonist, Fertirelin triggers an initial surge in FSH and LH (flare effect) within the first few days, followed by suppression. This biphasic response occurs in 60-80% of users and is expected. Animals may show increased reproductive behavior for 2-4 days before suppression begins.

Management: This is an expected physiologic response. Monitor for signs of exaggerated reproductive behavior. If using in breeding protocols, time applications accordingly. Discuss timing strategy with your veterinarian to optimize breeding outcomes.

Temporary behavioral changes in animals

Cattle and other livestock frequently show increased mounting behavior, vocalizations, and restlessness during the first 24-72 hours after injection, related to the initial hormone surge. These behavioral changes typically resolve as the flare effect subsides and suppression begins.

Management: Keep animals in secure enclosures during the first 48-72 hours post-injection. Provide adequate space and minimize handling stress. Separate animals if aggressive mounting occurs. These behaviors are temporary and expected, not a sign of adverse reactions.

Mild injection site reactions

Localized inflammation at the injection site occurs in approximately 15-20% of animals. This typically includes mild redness and slight induration that develops within hours and resolves within 3-7 days. Is rarely associated with infection or serious complications.

Management: Rotate injection sites between treatments to different areas of the neck or hindquarters. Use sterile injection technique. Apply ice packs if swelling is moderate. Monitor for signs of infection (increasing warmth, pus, fever). Most reactions resolve without intervention.

Short-term changes in appetite

Some animals experience decreased feed intake for 1-2 days immediately after Fertirelin injection, correlating with the behavioral changes from the initial hormone surge. Feed consumption typically normalizes by day 3-4 as hormone levels stabilize.

Management: Ensure animals have access to water and hay during the first few days. Continue offering feed even if intake is reduced; appetite usually returns spontaneously. Contact your veterinarian if appetite remains reduced beyond 4 days or if the animal appears distressed.

Temporary mood variations

Animals may appear more irritable or aggressive during the 24-72 hour period following injection due to elevated hormones. Restlessness and hyperreactivity are common. These mood changes correlate with the flare effect and typically resolve as LH suppression begins.

Management: Minimize stressful handling and procedures during the first 72 hours post-injection. Provide a calm environment. Avoid mixing treated and untreated animals if aggression is significant. These behavioral changes are temporary and expected with GnRH agonists.

Minimal systemic effects at therapeutic doses

Systemic side effects are uncommon at recommended veterinary doses (25-100 mcg). Most therapeutic responses are localized to reproductive and behavioral systems. Animals rarely show signs of systemic toxicity or off-target organ effects when using proper injection technique and staying within established dosing guidelines.

Management: Maintain strict adherence to veterinary dosing recommendations. Monitor general health status (appetite, activity, temperature) during the first week. Report any unexpected systemic signs (severe lethargy, vomiting, fever) to your veterinarian immediately, though these are rare.

Less Common

  • Occasional swelling at injection site

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

  • ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • ×Your healthcare provider recommends discontinuation based on your clinical response
  • ×Development of any new medical condition that may be contraindicated with Fertirelin
  • ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • ×Abnormal lab results or clinical markers that suggest adverse effects

Fertirelin should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

  • May be used together under medical guidance.
  • May be used together under medical guidance.
  • May be used together under medical guidance.

With medications

  • !Dopamine agonists - Use with caution—discuss with your healthcare provider.
  • !Other GnRH agonists without medical guidance - Use with caution—discuss with your healthcare provider.
  • !Certain anticonvulsants - Use with caution—discuss with your healthcare provider.

With supplements

  • Multivitamins - Generally safe to take alongside Fertirelin. Space doses apart if taking oral formulations to ensure optimal absorption.
  • Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Want the Full Picture?

View the complete Fertirelin research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.

View Full Fertirelin Profile

Medical Disclaimer

Fertirelin is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: 2/8/2026